Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.57 |
| ▸ | CA1 | P00915 | 5/20 | 0.57 |
| ▸ | CA9 | Q16790 | 5/20 | 0.57 |
| ▸ | CA2 | P00918 | 1/20 | 0.57 |
| ▸ | CA7 | P43166 | 1/20 | 0.57 |
| ▸ | RAB9A | P51151 | 4/20 | 0.47 |
| ▸ | NPC1 | O15118 | 3/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 5/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.46 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.46 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | GAA | P10253 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 1,4-Diallyloxybenzene SCHEMBL302448 | 0.92 | CA12 (0.63) | CA12CA1CA9CA2CA7 | |
| SCHEMBL5973615 | 0.91 | LTA4H (0.55) | CA12CA1CA9CA2CA7 | |
| SCHEMBL5773100 | 0.89 | ALDH1A1 (0.56) | CA12CA1CA9CA2CA7 | |
| SCHEMBL5973047 | 0.89 | CA12 (0.49) | CA12CA1CA9CA2CA7 | |
| SCHEMBL3548978 | 0.89 | HPGD (0.49) | CA12CA1CA9CA2CA7 | |
| SCHEMBL5208927 | 0.89 | CA12 (0.49) | CA12CA1CA9CA2CA7 | |
| SCHEMBL3416077 | 0.89 | LTA4H (0.57) | CA12CA1CA9CA2CA7 | |
| SCHEMBL28922902 | 0.88 | CA12 (0.47) | CA12CA1CA9CA2CA7 | |
| SCHEMBL22215859 | 0.86 | MEN1 (0.47) | CA12CA1CA9CA2CA7 | |
| SCHEMBL3971632 | 0.86 | CA12 (0.50) | CA12CA1CA9CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100056475-A1 | CYCLODEXTRIN CONJUGATES | RGO BIOSCIENCE LLC | 2010-03-04 | — | — | US | claimed |
| WO-2010017328-A2 | CYCLODEXTRIN CONJUGATES | RGO BIOSCIENCES LLC (US) | 2010-02-11 | — | — | WO | claimed |
| JP-1110649-A | — | — | None | — | — | JP | disclosed |
| US-11773207-B2 | Thiol compound, method for synthesizing same, and uses for said thiol compound | SHIKOKU CHEMICALS CORPORATION (JP) | 2023-10-03 | — | — | US | disclosed |
| US-11773207-B2 | Thiol compound, method for synthesizing same, and uses for said thiol compound | SHIKOKU CHEMICALS CORPORATION (JP) | 2023-10-03 | — | — | US | disclosed |
| WO-2020145111-A1 | THIOL COMPOUND, METHOD FOR SYNTHESIZING SAME, AND USES FOR SAID THIOL COMPOUND | 四国化成工業株式会社 | 2020-07-16 | — | — | WO | disclosed |
| EP-3290402-B1 | PROCESS FOR PRODUCING ALLYL-SUBSTITUTED BISPHENOL COMPOUND | NICCA CHEMICAL CO (JP) | 2019-11-20 | — | — | EP | disclosed |
| US-9963426-B1 | Process for producing allyl-substituted bisphenol compound | NICCA CHEMICAL CO., LTD. (JP) | 2018-05-08 | — | — | US | disclosed |
| US-20180118672-A1 | PROCESS FOR PRODUCING ALLYL-SUBSTITUTED BISPHENOL COMPOUND | NICCA CHEMICAL CO., LTD. (JP) | 2018-05-03 | — | — | US | disclosed |
| EP-3290402-A1 | PROCESS FOR PRODUCING ALLYL-SUBSTITUTED BISPHENOL COMPOUND | Nicca Chemical Co., Ltd. (JP) | 2018-03-07 | — | — | EP | disclosed |
| US-9704997-B2 | Photopatternable materials and related electronic devices and methods | FLEXTERRA, INC. (US) | 2017-07-11 | — | — | US | disclosed |
| US-20100056475-A1 | CYCLODEXTRIN CONJUGATES | RGO BIOSCIENCE LLC | 2010-03-04 | — | — | US | disclosed |
| WO-2010017328-A2 | CYCLODEXTRIN CONJUGATES | RGO BIOSCIENCES LLC (US) | 2010-02-11 | — | — | WO | disclosed |
| EP-0441047-B1 | Thermosettable composition | MINNESOTA MINING & MFG (US) | 1996-06-05 | — | — | EP | disclosed |
| US-5462996-A | Providing a composition with low viscosity for compounding but having an increase in viscosity at cure temperatures | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1995-10-31 | — | — | US | disclosed |
| US-5405686-A | Woven and non-woven web, film or foil; prepregs; polyepoxides, polyetherimides, blends | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1995-04-11 | — | — | US | disclosed |
| US-5368922-A | Polymer and fiber blends for hot melt compositions | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1994-11-29 | — | — | US | disclosed |
| US-5276106-A | Decreasing viscosity with increasing temperature up to dissolution temperature, then increasing viscosity with temperature, rheology control | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1994-01-04 | — | — | US | disclosed |
| EP-0441047-A2 | Thermosettable composition | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1991-08-14 | — | — | EP | disclosed |
| JP-H01110649-A | ALLYLPHENOL DERIVATIVE | CHISSO CORP | 1989-04-27 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100056475-A1 | CYCLODEXTRIN CONJUGATES | CLTC, CDV3, CLINT1 | CA12 255/4885CA1 631/4885CA9 559/4885 |
| US-20180118672-A1 | PROCESS FOR PRODUCING ALLYL-SUBSTITUTED BISPHENOL COMPOUND | ACSL3, BRSK1, CCNL2 | CA12 2475/4885CA1 2639/4885CA9 1532/4885 |
| US-11773207-B2 | Thiol compound, method for synthesizing same, and uses for said thiol compound | TST, TMT1A, CTH | CA12 2561/4885CA1 1231/4885CA9 2520/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.